91AV

Introduction

In the main there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems. The difference between success and failure is how we, as medicinal chemists, tackle and resolve the problems.

Deadlines

• Nov 06 2014
  Early bird registration deadline

  
• Jan 15 2015
  Standard registration deadline

  
• Jan 29 2015
  Bursary application deadline

  

Useful links

Downloads

• Delegate registration form
• Bursary application form
• Second announcement

Speakers

• Simon Campbell Consultant, United Kingdom
• Hugo Kubinyi BASF SE and University of Heidelberg (retired), Germany
• Paul Leeson Paul Leeson Consulting Ltd, United Kingdom
• Jack Li University of San Francisco, United States
• John Dixon JD International Consulting, United Kingdom
• Youssef L Bennani Vertex Pharmaceuticals (Canada) Inc, Canada

---

Sponsorship & supporting organisations

---

Sponsors

RSC 91AV and Biology Interface Division and to RSC Organic Division

Venue

The 91AV, Burlington House

Library, The 91AV, Burlington House, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee

• Nadia Ahmad Vertex Pharmaceuticals, United Kingdom
• David Alker Dave Alker Associates, United Kingdom
• Gordon Saxty Fidelta, Croatia
• Joe Sweeney University of Huddersfield, United Kingdom

---

Organised by

RSC-BMCS

Contact information

Mrs Maggi Churchouse
Maggi Churchouse Events
3 East Barn, Market Weston Road, Thelnetham, Diss, IP22 1JJ, United Kingdom
+44 (0)1359 221004
Contact us by email

---